Both groups displayed significant comparable weight loss, improvement of the glycemic values, and reductions of the BMI, IL-1β level, and NAFLD degree assessed by magnetic resonance [54]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.